bf/AMEX:ASXC_icon.png

COM:ASENSUS

Asensus Surgical

  • Stock

USD

Last Close

0.35

21/08 20:00

Market Cap

91.27M

Beta: -

Volume Today

3.94M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
350.50K
-
1.96M
459.63%
5.90M
200.94%
9.35M
58.39%
10.88M
16.35%
10.80M
0.75%
10.34M
4.20%
9.33M
9.76%
8.46M
9.37%
7.73M
8.64%
average payables
1.79M
-
3.11M
74.08%
4.22M
35.64%
3.88M
8.05%
4.10M
5.79%
4.01M
2.34%
2.77M
30.80%
2.71M
2.36%
3.40M
25.55%
3.75M
10.26%
average receivables
195K
-
108K
44.62%
357.50K
231.02%
1.84M
413.43%
5.81M
216.64%
4.60M
20.80%
867.50K
81.15%
1.59M
83.00%
2.44M
53.39%
3.16M
29.73%
book value per share
2.07
-
2.23
7.33%
1.05
52.81%
1.20
14.44%
10.57
779.38%
3.13
70.39%
0.87
72.23%
0.75
14.24%
0.42
43.50%
0.13
68.24%
capex per share
-0.04
-
-0.02
58.15%
-0.01
21.72%
-0.01
10.33%
-0.05
260.93%
-0.02
49.00%
-0.00
99.83%
-0.01
14,126.69%
-0.01
10.27%
-0.00
58.46%
capex to depreciation
-1.66
-
-0.36
78.34%
-0.15
57.50%
-0.19
26.00%
-0.06
69.89%
-0.04
39.51%
-0.00
99.38%
-0.10
44,168.61%
-0.12
19.11%
-0.15
30.28%
capex to operating cash flow
0.07
-
0.03
51.02%
0.03
18.92%
0.05
92.57%
0.02
68.26%
0.01
62.55%
0.00
98.92%
0.03
52,247.08%
0.02
35.50%
0.01
59.37%
capex to revenue
-5.42
-
-0.90
-
-0.28
68.75%
-0.03
88.59%
-0.05
60.34%
-0.00
98.16%
-0.17
17,487.46%
-0.18
8.60%
-0.07
63.76%
cash per share
0.59
-
0.48
18.45%
0.22
55.39%
0.61
184.70%
4.57
645.36%
0.54
88.16%
0.23
57.30%
0.43
87.60%
0.30
31.21%
0.08
71.71%
days of inventory on hand
655.33
-
2.69K
310.72%
586.92
78.19%
246.95
57.92%
187.56
24.05%
708.95
277.98%
284.01
59.94%
278.11
2.08%
192.37
30.83%
days payables outstanding
589.33
-
743.36
26.14%
1.36K
82.99%
204.61
84.96%
100.06
51.10%
63.01
37.02%
138.84
120.33%
113.42
18.31%
112.40
0.90%
111.18
1.09%
days sales outstanding
121.97
-
152.10
-
155.94
2.52%
130.03
16.62%
26.53
79.60%
128.18
383.21%
91.34
28.74%
144.72
58.45%
149.29
3.15%
debt to assets
0.07
-
0.08
8.49%
0.07
7.06%
0.05
28.59%
0.12
132.76%
0.05
61.80%
0.04
23.15%
0.03
15.19%
0.05
56.41%
0.09
96.70%
debt to equity
0.08
-
0.11
37.03%
0.11
0.90%
0.07
33.18%
0.17
136.22%
0.06
63.78%
0.05
27.45%
0.03
26.48%
0.06
65.34%
0.17
205.97%
dividend yield
0.01
-
earnings yield
-0.02
-
-0.02
7.88%
-0.06
246.04%
-0.04
38.69%
-0.13
240.04%
-5.91
4,382.79%
-1.33
77.52%
-0.25
81.35%
-0.92
271.26%
-0.99
7.01%
enterprise value
2.20B
-
2.55B
16.04%
1.88B
26.04%
3.65B
93.87%
476.13M
86.97%
17.59M
96.31%
31.06M
76.61%
239.49M
671.00%
81.30M
66.05%
68.21M
16.10%
enterprise value over ebitda
-62.22
-
-72.24
16.11%
89.54
223.94%
99.21
10.80%
-9.81
109.89%
-0.22
97.75%
-0.72
227.19%
-4.77
560.57%
-1.28
73.15%
-0.92
28.46%
ev to operating cash flow
-66.10
-
-66.18
0.12%
-35.98
45.63%
-91.82
155.21%
-9.82
89.31%
-0.24
97.56%
-0.67
178.06%
-5.89
785.08%
-1.38
76.58%
-1.07
22.28%
ev to sales
5.48K
-
1.24K
-
513.84
58.59%
19.75
96.16%
2.06
89.56%
9.78
374.55%
29.09
197.37%
11.47
60.57%
7.95
30.67%
free cash flow per share
-0.60
-
-0.50
17.22%
-0.48
4.01%
-0.28
41.36%
-3.09
1,000.26%
-4.17
34.83%
-0.66
84.18%
-0.19
71.91%
-0.25
37.50%
-0.26
0.96%
free cash flow yield
-0.02
-
-0.02
2.87%
-0.03
83.12%
-0.01
60.50%
-0.11
839.60%
-2.84
2,594.85%
-1.05
63.09%
-0.17
84.06%
-0.73
339.73%
-0.81
9.89%
graham net net
0.37
-
-0.39
206.09%
-0.27
31.45%
0.18
169.61%
0.88
374.25%
-0.22
124.78%
0.08
135.92%
0.38
391.22%
0.26
33.43%
0.00
99.74%
graham number
5.47
-
5.43
0.66%
5.03
7.48%
5.13
2.06%
30.37
491.73%
24.75
18.50%
4.05
83.64%
2.15
46.92%
1.74
19.01%
0.97
44.12%
income quality
0.88
-
0.82
7.05%
0.44
46.77%
0.27
37.05%
0.78
185.61%
0.48
39.29%
0.79
65.13%
0.65
17.28%
0.78
19.83%
0.81
4.00%
intangibles to total assets
0.71
-
0.78
9.96%
0.69
11.64%
0.50
28.24%
0.55
10.13%
0.42
23.87%
0.28
31.51%
0.05
81.36%
0.01
74.40%
0.02
50.48%
interest coverage
35.10
-
28.96
17.48%
65.46
126.00%
22.42
65.75%
-11.68
152.10%
-33.51
186.87%
-3.18K
9,385.24%
-174.65
94.51%
-184.58
5.69%
interest debt per share
0.15
-
0.23
51.07%
0.10
56.50%
0.07
29.28%
2.10
2,905.53%
0.46
78.26%
0.04
91.25%
0.03
33.30%
0.03
5.79%
0.02
9.52%
inventory turnover
0.56
-
0.14
75.65%
0.62
358.59%
1.48
137.67%
1.95
31.66%
0.51
73.54%
1.29
149.62%
1.31
2.12%
1.90
44.57%
invested capital
0.08
-
0.11
37.03%
0.11
0.90%
0.07
33.18%
0.17
136.22%
0.06
63.78%
0.05
27.45%
0.03
26.48%
0.06
65.34%
0.17
205.97%
market cap
2.22B
-
2.57B
15.58%
1.90B
26.15%
3.73B
96.84%
468.26M
87.45%
26.07M
94.43%
44.61M
71.09%
251.93M
464.73%
82.09M
67.42%
79.62M
3.00%
net current asset value
22.27M
-
-22.18M
199.62%
-20.36M
8.20%
41.59M
304.25%
30.80M
25.95%
8.71M
71.71%
17.32M
98.87%
96.07M
454.55%
70.47M
26.65%
9.27M
86.85%
net debt to ebitda
0.70
-
0.53
24.66%
-0.53
199.96%
-2.12
299.23%
-0.16
92.34%
0.11
165.65%
0.32
195.77%
0.25
21.33%
0.01
94.97%
0.15
1,130.42%
net income per share
-0.64
-
-0.59
8.06%
-1.07
81.39%
-0.97
8.98%
-3.88
298.18%
-8.69
124.29%
-0.84
90.37%
-0.28
67.14%
-0.32
16.10%
-0.31
1.68%
operating cash flow per share
-0.57
-
-0.48
14.55%
-0.47
3.44%
-0.27
42.71%
-3.04
1,037.25%
-4.14
36.17%
-0.66
84.09%
-0.18
72.82%
-0.25
39.11%
-0.25
2.25%
payables turnover
0.62
-
0.49
20.72%
0.27
45.35%
1.78
564.82%
3.65
104.49%
5.79
58.79%
2.63
54.61%
3.22
22.41%
3.25
0.91%
3.28
1.10%
receivables turnover
2.99
-
2.40
-
2.34
2.46%
2.81
19.93%
13.76
390.17%
2.85
79.31%
4.00
40.34%
2.52
36.89%
2.44
3.06%
research and ddevelopement to revenue
69.69
-
19.27
-
3.09
83.95%
0.91
70.72%
2.63
190.87%
5.23
98.77%
2.35
55.10%
4.08
73.75%
4.32
5.70%
return on tangible assets
-0.96
-
-0.86
10.21%
-2.20
154.54%
-1.15
47.86%
-0.57
50.45%
-3.53
520.77%
-1.06
69.97%
-0.35
66.61%
-0.66
86.60%
-1.32
100.39%
revenue per share
0.01
-
0.01
-
0.05
253.08%
1.51
3,063.21%
0.48
68.19%
0.04
90.68%
0.04
19.11%
0.03
17.38%
0.03
14.63%
roe
-0.31
-
-0.26
14.34%
-1.02
284.36%
-0.81
20.46%
-0.37
54.72%
-2.78
657.44%
-0.96
65.31%
-0.37
61.69%
-0.76
105.47%
-2.35
209.55%
roic
-0.28
-
-0.23
17.14%
-0.90
292.11%
-0.32
65.09%
-0.24
25.29%
-2.52
969.31%
-0.90
64.07%
-0.36
60.32%
-0.69
91.17%
-1.79
161.27%
sales general and administrative to revenue
15.57
-
7.12
-
1.73
75.75%
0.57
66.70%
2.20
282.53%
4.45
102.50%
2.35
47.28%
2.85
21.26%
2.23
21.54%
shareholders equity per share
2.07
-
2.23
7.33%
1.05
52.81%
1.20
14.44%
10.57
779.38%
3.13
70.39%
0.87
72.23%
0.75
14.24%
0.42
43.50%
0.13
68.24%
stock based compensation to revenue
4.59
-
3.31
-
1.00
69.96%
0.38
62.32%
1.35
259.69%
2.49
84.71%
1.15
54.03%
1.19
3.68%
0.92
22.26%
tangible asset value
25.70M
-
-17.00M
166.15%
-3.84M
77.43%
54.84M
1,529.29%
37.93M
30.84%
24.47M
35.48%
39.30M
60.62%
159.35M
305.46%
98.07M
38.46%
32.18M
67.19%
tangible book value per share
0.44
-
-0.21
148.78%
-0.03
83.98%
0.37
1,178.00%
2.38
545.42%
1.38
42.03%
0.56
59.77%
0.70
26.50%
0.41
40.94%
0.13
68.92%
working capital
31.54M
-
18.07M
42.71%
7.33M
59.45%
84.15M
1,048.55%
79.76M
5.22%
14.93M
81.28%
23.73M
58.92%
103.45M
335.93%
76.46M
26.09%
23.76M
68.93%

All numbers in USD (except ratios and percentages)